The WHO estimates the average medication adherence rate is 50% in developed nations, though the U.S. trails other countries in reported adherence on Medisafe.…

AstraZeneca

Shire and Pfizer aside, pharma took an M&A break last year to await U.S. election results: report

AstraZeneca's latest Kondo-izing move: A $250M-plus deal for cancer med Zoladex

AZ looks to extend PARP lead with solid Lynparza breast cancer data

With Siliq approval, can Amgen and AZ's trash become Valeant's treasure?

Senator says drugmakers may be misusing FDA orphan drug rules—and costing taxpayers money

Diabetes drugs pop on January's TV ad spending list, but AbbVie's Humira stays at the top

AZ chief: Durvalumab's ready for a 'marketing battle' against I-O heavyweights Opdivo, Keytruda

AstraZeneca CEO Soriot's comp expected to take a hit, which some think will be good for investors

FiercePharmaAsia: FibroGen and AZ’s anemia filing in China, Astellas’ eardrum therapy buy, Takeda’s price control promise

Floundering AZ's sales tanked in Q4—and that won't change this year, execs warn